Post-approval commitment for NMPA-2021-0064. Category: Paediatric Study. Priority: high.

Commitment ID
COM-064
Application
Authority
National Medical Products Administration
Category
Paediatric Study
Priority
high
Status
Blocked
Due Date
2025-03-25
Completed At
—
Owner
Lieselotte van der Berg
Created
2023-06-23
Description

Provide confirmatory bioequivalence study for 200 mg strength

Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.